Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > NR
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(10)
•••
Comment by prosciuttoon Dec 06, 2021 3:39pm
203 Views
Post# 34203494

RE:RE:RE:RE:RE:RE:NR

RE:RE:RE:RE:RE:RE:NRThey need to be very cautious about a new CEO. I think thats where they f'ed up most over the last 10 years. A scientist can NOT be a CEO. Taking a 2 year MBA on top of decades of science doesnt  instantly make someone executive material either. The job of as CEO is to listen to, absorb & understand everything that will affect the company. He/she needs to take advice from different spheres and be able to communicate effectively.  They also need to think long and hard about  compensation, but thats another story.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities